Replimune (REPL) Short-term Investments (2018 - 2025)
Replimune has reported Short-term Investments over the past 8 years, most recently at $146.2 million for Q4 2025.
- Quarterly results put Short-term Investments at $146.2 million for Q4 2025, down 59.87% from a year ago — trailing twelve months through Dec 2025 was $146.2 million (down 59.87% YoY), and the annual figure for FY2025 was $372.7 million, up 7.65%.
- Short-term Investments reached $146.2 million in Q4 2025 per REPL's latest filing, down from $221.3 million in the prior quarter.
- Across five years, Short-term Investments topped out at $436.8 million in Q1 2023 and bottomed at $146.2 million in Q4 2025.
- Median Short-term Investments over the past 5 years was $311.7 million (2024), compared with a mean of $322.0 million.
- The largest annual shift saw Short-term Investments skyrocketed 169.39% in 2021 before it plummeted 59.87% in 2025.
- Over 5 years, Short-term Investments stood at $287.9 million in 2021, then surged by 42.31% to $409.7 million in 2022, then dropped by 10.01% to $368.7 million in 2023, then dropped by 1.19% to $364.3 million in 2024, then tumbled by 59.87% to $146.2 million in 2025.
- Business Quant data shows Short-term Investments for REPL at $146.2 million in Q4 2025, $221.3 million in Q3 2025, and $306.0 million in Q2 2025.